Warburg Pincus LLC
07/15/2026 | Press release | Distributed by Public on 07/15/2026 08:53
Warburg Pincus Acquires Integrace, an Orthopedics and Gynecology-Focused Pharmaceuticals CompanyJul 15, 2026
Mumbai, July 15, 2026: Warburg Pincus, the pioneer of global growth investing, today announced the acquisition of Integrace Private Limited ("Integrace" or the "Company"), a leading domestic formulations company focused on orthopedics and gynecology.
Integrace has built a differentiated portfolio of more than 20 brands across attractive high-growth markets. Through its scientific marketing practices, the Company has built trusted relationships with over 45,000 healthcare professionals across India, supported by a high-quality specialist prescriber base across orthopedics and gynecologists.
Industry veteran Rehan Khan, former Managing Director at MSD and Abbott India Limited,will join Integrace as Chief Executive Officer to lead the Company's next phase of growth in partnership with Warburg Pincus.
India's pharmaceutical market continues to offer compelling long-term growth opportunities, driven by healthcare awareness, rising incomes, and expanding access to quality care. Warburg Pincus believes the sector is well positioned for the creation of scaled, therapy-focused platforms through strategic consolidation.
Himanshu Nema, Managing Director, Warburg Pincus, said, "Integrace has built an exceptional foundation with a differentiated portfolio in orthopedics and gynecology, a strong position in the high-growth therapeutics segments and trusted relationships with specialists. This acquisition reflects our conviction in therapy-focused, brand-led platforms and our ambition to build a scaled, market-leading pharmaceuticals business in India. We are excited to partner with Rehan and the team on this journey."
Rehan Khan, Chief Executive Officer, Integrace, said, "India's pharmaceutical market is large and attractive with predictable growth over the long-term, particularly in women's health and orthopedic therapies. Integrace has built a strong platform through its differentiated portfolio, deep scientific strengths, and trusted relationships with healthcare professionals. With Warburg Pincus' business-building expertise and healthcare investing experience, we look forward to building a scaled therapy-focused domestic formulations platform in India."
As part of the transaction, existing shareholders True North and Temasek will fully exit their investment in the Company.
Satish Chander, Partner, True North, said, "We are proud to have partnered with the Integrace team as they built it into a strong quality healthcare company that established a deep and respectable position amongst specialists through its science-based marketing practices. We wish Rehan, Warburg Pincus and the entire team continued success in the next phase of growth."
Warburg Pincus has been investing in India for three decades and, over time, has built one of the country's most established healthcare investment franchises. The firm has partnered with leading businesses across pharmaceuticals, medical technology, healthcare services and life sciences, including Metropolis, Laurus Labs, MedPlus, Meril Life Sciences and Appasamy Associates. The investment in Integrace builds on this long-standing track record of partnering with exceptional management teams to create scaled, market-leading healthcare businesses.
About Warburg Pincus
Warburg Pincus LLC is the pioneer of global growth investing. A private partnership since 1966, the firm has the flexibility and experience to focus on helping investors and management teams achieve enduring success across market cycles. Today, the firm has more than $105 billion in assets under management, and more than 225 companies in its active portfolio, diversified across stages, sectors, and geographies. Warburg Pincus has invested in more than 1,100 companies across its private equity, real estate, and capital solutions strategies.
The firm is headquartered in New York with more than 15 offices globally. For more information, please visit www.warburgpincus.com or follow us on LinkedIn and YouTube.
About Integrace
Integrace is one of India's leading orthopedics and gynecology-focused domestic formulations companies. The Company has a portfolio of 20+ products catering to pain management, pregnancy and women's health, with 5 power brands ranking among the top 3 in their respective markets. Supported by science-backed marketing, the Company has cultivated a high-quality specialist coverage base of over 45,000 healthcare professionals across orthopedics and gynecologists.
About True North
Founded in 1999 by Vishal Nevatia, True North is one of India's most respected home-grown private equity firms. In Private Equity, True North has successfully raised seven separate investment funds with a combined corpus of ~ USD 3 billion, including co-investments. True North's deep insights and understanding of India has added value to more than 60 businesses over the last 25 years across sectors such as consumer, financial services, healthcare, and technology.
For information, please contact:
Malini Roy
Warburg Pincus
Warburg Pincus LLC published this content on July 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 15, 2026 at 14:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]